Who owns WEREWOLF THERAPEUTICS INC?
- Ticker: HOWL
- CUSIP Number: 95075a107
Tip: Access positions for across all investors
Analyze quarterly positions in Werewolf Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Werewolf Therapeutics stock
Who bought or sold WEREWOLF THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 6.7M | $5.6M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 1.2M | $1.0M | 100% | Mar 2026 |
|
| MPM Oncology Impact Management | 1.2M | $1.0M | -13% | Mar 2026 |
|
| Lynx1 Capital Management | 658k | $548k | 0% | Mar 2026 |
|
| Sphera Funds Management | 627k | $522k | 0% | Mar 2026 |
|
| DC Funds | 589k | $491M | 0% | Mar 2026 |
|
| Squadron Capital Management | 564k | $469k | 100% | Mar 2026 |
|
| Renaissance Technologies | 516k | $430k | -24% | Mar 2026 |
|
| Geode Capital Management | 390k | $324k | 16% | Mar 2026 |
|
| Bank of America Corporation | 265k | $220k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 158k | $131k | 100% | Mar 2026 |
|
| Millennium Management | 132k | $110k | -45% | Mar 2026 |
|
| State Street Corporation | 119k | $99k | 0% | Mar 2026 |
|
| BlackRock | 102k | $85k | 0% | Mar 2026 |
|
| Northern Trust | 87k | $72k | 0% | Mar 2026 |
|
| Alyeska Investment Group | 87k | $72k | -63% | Mar 2026 |
|
| Jane Street | 83k | $69k | -47% | Mar 2026 |
|
| Bridgeway Capital Management | 77k | $64k | 0% | Mar 2026 |
|
| UBS Group | 67k | $56k | 10% | Mar 2026 |
|
| XTX Topco | 51k | $42k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 38k | $32k | 12% | Mar 2026 |
|
| Morgan Stanley | 34k | $28k | -27% | Mar 2026 |
|
| Simplex Trading | 33k | $27k | 35% | Mar 2026 |
|
| Verdad Advisers | 30k | $25k | 100% | Mar 2026 |
|
| Raymond James Financial | 20k | $17k | 100% | Mar 2026 |
|
| Hrt Financial | 18k | $14k | 100% | Mar 2026 |
|
| Camden Capital | 15k | $13k | 0% | Mar 2026 |
|
| Delta Investment Management | 15k | $12k | 0% | Mar 2026 |
|
| Barclays | 13k | $11k | 0% | Mar 2026 |
|
| HBK Sorce Advisory | 13k | $9.0k | 0% | Mar 2026 |
|
| Larson Financial Group | 13k | $11k | 0% | Mar 2026 |
|
| Pacitti Group | 12k | $10k | 0% | Mar 2026 |
|
| Citadel Advisors | 10k | $8.6k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 10k | $8.6k | 100% | Mar 2026 |
|
| Cetera Investment Advisers | 10k | $8.5k | 0% | Mar 2026 |
|
| LPL Financial | 10k | $8.3k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 8.6k | $7.2k | 0% | Mar 2026 |
|
| Financial Perspectives | 6.8k | $5.6k | 0% | Mar 2026 |
|
| TFC Financial Management | 4.5k | $3.7k | 0% | Mar 2026 |
|
| Citigroup | 3.4k | $2.8k | 100% | Mar 2026 |
|
| Group One Trading | 1.9k | $1.6k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 790.00 | $657.991000 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 200.00 | $167.000000 | 4900% | Mar 2026 |
|
| SBI Securities | 80.00 | $67.000000 | 100% | Mar 2026 |
|
| FMR | 39.00 | $31.999500 | -99% | Mar 2026 |
|
| Optiver Holding B.V. | 22.00 | $18.000400 | 0% | Mar 2026 |
|
| SRS Capital Advisors | 12.00 | $32.000400 | -69% | Mar 2026 |
|
Who sold out of Werewolf Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Dec 2025 | 100k | $63k |
| Vontobel Holding | Dec 2025 | 60k | $38k |
| Regal Investment Advisors | Dec 2025 | 53k | $33k |
| Edgewood Management | Dec 2025 | 50k | $32k |
| Point72 Asset Management | Dec 2025 | 15k | $9.2k |
| Engineers Gate Manager | Dec 2025 | 12k | $7.7k |
| Highline Wealth Partners | Dec 2025 | 12k | $7.6k |
| Intl Fcstone | Dec 2025 | 11k | $6.7k |
| Two Sigma Advisers | Dec 2025 | 10k | $6.5k |
| Federated Investors | Dec 2025 | 4.4k | $2.8k |
| NISA Investment Advisors | Dec 2025 | 345.00 | $219.006000 |